Profound Medical Corp.

NASDAQ: PROF · Real-Time Price · USD
4.66
-0.88 (-15.88%)
At close: Aug 15, 2025, 12:20 PM

Profound Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
11.39M 10.68M 8.98M 7.88M 7.25M 7.2M 6.45M 6.75M 7.18M 6.68M 6.42M 6.92M 7.53M 6.87M 8.72M 8.41M 6.83M
Cost of Revenue
3.77M 3.64M 3.41M 3.05M 2.81M 2.82M 2.56M 2.84M 3.38M 3.66M 3.46M 4.07M 4.39M 3.92M 5.14M 4.35M 3.56M
Gross Profit
7.6M 7.02M 5.55M 4.83M 4.44M 4.38M 3.88M 3.91M 3.8M 3.02M 2.96M 2.86M 3.14M 2.95M 3.59M 4.07M 3.27M
Operating Income
-21.09M -17.41M -17.43M -14.99M -16.39M -15.74M -13.26M -14.93M -29.15M -29.6M -33.03M -32.41M -31.01M -30.29M -53.52M -40.79M -30.41M
Interest Income
1.33M 2.18M 3.23M 4.02M 3.55M 2.86M 2.02M 1.25M 1.17M 1.09M 658K 432K 235K 205K 337.87K 547.93K 702.83K
Pretax Income
-32.34M -27.82M -31.39M -27.74M -28.16M -28.7M -28.88M -28.3M -26.89M -28.38M -29.25M -30.23M -31.31M -30.59M -28.13M -28.09M -26.34M
Net Income
-31.81M -27.29M -31.39M -27.59M -28.03M -28.57M -29.19M -28.62M -27.2M -28.67M -29.3M -30.3M -31.41M -30.7M -27.9M -27.98M -26.32M
Selling & General & Admin
26.51M 23.11M 22.39M 19.98M 19.23M 18.62M 16.52M 16.9M 17.6M 17.93M 19.69M 19.64M 18.8M 17.97M 15.89M 14.38M 12.87M
Research & Development
17.85M 16.98M 16.26M 15.51M 14.47M 14.38M 13.5M 14.82M 15.35M 14.69M 16.3M 15.62M 15.35M 15.28M 13.04M 12.53M 10.86M
Other Expenses
n/a n/a n/a n/a -12.87M -12.87M -12.87M -12.87M n/a n/a n/a n/a n/a n/a n/a -0.00 -0.00
Operating Expenses
28.7M 24.43M 22.99M 19.82M 33.7M 33M 30.01M 31.72M 32.95M 32.62M 35.99M 35.26M 34.15M 33.24M 28.92M 26.91M 23.73M
Interest Expense
471.04K n/a -404.48K -603.48K -261.69K 401.36K 514.74K 528.74K 350.21K 174.19K 630.92K 638.92K 645.92K 651.92K 66.22K 67.39K 67.49K
Selling & Marketing Expenses
5.88M 8.31M 11.23M 10.5M 9.78M 9.45M 8.21M 8.23M 8.37M 8.47M 9.1M 8.93M 8.27M 7.65M 7.06M 6.21M 5.49M
Cost & Expenses
48.15M 43.75M 42.08M 38.54M 23.64M 22.94M 19.71M 21.69M 36.33M 36.28M 39.45M 39.33M 38.54M 37.16M 34.06M 31.26M 27.29M
Income Tax Expense
n/a -2K 7K -152K -137K -128K 307K 323K 304K 287K 50K 68K 109K 105K -236.99K -107.47K -23.31K
Shares Outstanding (Basic)
30.04M 25.77M 24.64M 24.44M 23.84M 21.37M 21.28M 21.17M 20.92M 20.71M 20.82M 20.79M 20.78M 20.78M 20.41M 20.35M 20.28M
Shares Outstanding (Diluted)
30.04M 25.77M 24.64M 24.44M 23.84M 21.37M 21.4M 21.17M 20.92M 20.86M 20.86M 20.79M 20.78M 20.78M 20.41M 20.35M 20.28M
EPS (Basic)
-1.22 -1.12 -1.34 -1.22 -1.29 -1.35 -1.39 -1.37 -1.31 -1.39 -1.42 -1.47 -1.53 -1.5 -1.38 -1.41 -1.39
EPS (Diluted)
-1.22 -1.12 -1.34 -1.22 -1.29 -1.35 -1.39 -1.37 -1.31 -1.39 -1.42 -1.47 -1.53 -1.5 -1.37 -1.4 -1.38
EBITDA
-35.95M -32.61M -31.72M -29.79M -28.4M -27.3M -27.82M -28.89M -29.63M -29.81M -31.19M -30.18M -29.77M -30.06M -27.71M -26.36M -24.81M
EBIT
-37.02M -33.34M -32.67M -29.97M -28.57M -27.93M -29.03M -30.7M -30.16M -31.49M -32.49M -30.18M -31.25M -30.53M -28.07M -28.05M -26.23M
Depreciation & Amortization
794K 1.04M 1.37M 1.49M 1.48M 1.45M 1.39M 1.5M 1.86M 2.08M 2.36M 2.48M 2.42M 2.36M 2.12M 1.9M 1.72M